サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：酸化ストレスアッセイの市場規模・シェア・動向分析 (～2030年)：製品・検査タイプ・技術・疾患タイプ・エンドユーザー・地域別の展望・競合戦略
市場調査レポート
商品コード
1068143

酸化ストレスアッセイの市場規模・シェア・動向分析 (～2030年)：製品・検査タイプ・技術・疾患タイプ・エンドユーザー・地域別の展望・競合戦略

Global Oxidative Stress Assays Market Size, Share & Trends Analysis By Product, By Test Type, By Technology, By Disease Type, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 235 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
酸化ストレスアッセイの市場規模・シェア・動向分析 (～2030年)：製品・検査タイプ・技術・疾患タイプ・エンドユーザー・地域別の展望・競合戦略
出版日: 2022年03月30日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の酸化ストレスアッセイの市場規模は予測期間中8.6%のCAGRで推移し、2030年には18億9,800万米ドルの規模に成長すると予測されています。慢性疾患や生活習慣病の拡大がバイオ医薬品やバイオテクノロジー企業の成長につながり、酸化ストレスアッセイ市場の成長をさらに後押ししています。

当レポートでは、世界の酸化ストレスアッセイの市場を調査し、市場概要、市場成長への各種影響因子の分析、主要動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長要因・抑制要因・機会・課題の分析
  • COVID-19：酸化ストレスアッセイ市場への影響

第5章 市場可変因子・展望

  • SWOT分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • ヒートマップ分析

第6章 世界の酸化ストレスアッセイ市場：製品別

  • 消耗品
  • キット
  • 試薬
  • 機器
  • サービス

第7章 世界の酸化ストレスアッセイ市場：検査タイプ別

  • 抗酸化能アッセイ
  • アスコルビン酸アッセイ
  • グルタチオンアッセイ
  • 細胞ベース外因性抗酸化アッセイ
  • 間接アッセイ
  • 脂質ベースアッセイ
  • 核酸ベースアッセイ
  • タンパク質ベースアッセイ
  • 酵素ベースアッセイ
  • 活性酸素種ベースアッセイ

第8章 世界の酸化ストレスアッセイ市場：技術別

  • 酵素免疫測定法 (ELISA)
  • フローサイトメトリー
  • ハイコンテントスクリーニング (HCS)
  • ラベルフリー検出
  • 顕微鏡検査
  • クロマトグラフィー

第9章 世界の酸化ストレスアッセイ市場：疾患タイプ別

  • 循環器疾患
  • 糖尿病
  • 癌
  • 呼吸器疾患
  • その他

第10章 世界の酸化ストレスアッセイ市場：エンドユーザー別

  • 臨床ラボ
  • CRO
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 化粧品企業

第11章 世界の酸化ストレスアッセイ市場：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第12章 企業プロファイル

  • Abcam, plc
  • AMS Biotechnology
  • Arbor Assays
  • BioVision, Inc.
  • Callegari SRL
  • Cayman Chemical
  • Cell Biolabs, Inc.
  • Eagle Biosciences, Inc.
  • Enzo Biochem, Inc.
  • Genox Corporation
  • Hycult Biotech
  • ImmunoChemistry Technologies, LLC
  • Kamiya Biomedical Company
  • MEGA TIP San.Tic.Ltd.Sti.
  • Merck KGaA
  • Oxford Biomedical Research
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Toxys B.V.
目次
Product Code: BIOT2212

Global oxidative stress assays market is projected to be worth USD 1898 million by 2030.

According to SPER Market Research, the oxidative stress assays market is estimated to reach USD 1898 million by 2030 with a CAGR of 8.6%. Rising prevalence of chronic and lifestyle disorders has led to the growth of biopharmaceutical and biotechnology companies which is further driving the growth of oxidative stress assays market.

Impact of COVID-19 on the Oxidative Stress Assays Market

COVID-19 has a slightly negative impact on oxidative stress assays market due to economic impact on companies, stringent regulatory process, disruptions in supply chain impacting the research activities. In upcoming years, academic research activities will rise leading to growth of oxidative stress assays market.

Scope of the report:

Market size available for years:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered

  • By Product, By Test Type, By Technology, By Disease, By End User

Geographies covered

  • North America, Europe, APAC, Latin America and the Middle East & Africa

Companies Covered

  • Abcam, plc, AMS Biotechnology, Arbor Assays, BioVision, Inc., Callegari SRL, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, ImmunoChemistry Technologies, LLC, Kamiya Biomedical Company, MEGA TIP San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Toxys B.V.

Driver: Rapidly growing biotechnology and biopharmaceutical industries

The biopharmaceutical and biotechnological industries are growing with technological advancements and rising demand. Oxidative stress assays are applied in both biopharmaceutical and biotechnological companies in cell cultures. Growth of these industries can drive the growth of oxidative stress assays market in the forecast period.

Restraints: Highly costly instruments

Advanced technologies for oxidative stress assays such as label-free detection and high-content screening are advantageous with advanced features and functions as compared to conventional technologies. Therefore, such instruments are priced at a premium cost. Companies with limited R&D budgets can not afford these instruments. The pharmaceutical companies require large number of such systems, thus overall cost of ownership combined with maintenance and indirect costs becomes very high. Thus, the cost of these instruments can restrain the growth of this market.

Opportunity: Growth opportunities in emerging economies

Emerging economies such as Russia, China, Brazil, India are offering growth opportunities to oxidative stress assays market. Factor attributing these opportunities is increasing R&D funding and investments for research organizations. Asian countries such as India and China have CROs that provide drug discovery services to pharmaceutical industries. The outsourcing of research work helps in increasing the efficiency in limited time.

Oxidative Stress Assays Market by Product:

Based on product, market has been segmented into Consumables, Kits, Reagents, Instruments, Services

Oxidative Stress Assays Market by Test Type:

Based on test type, the market is segmented into Antioxidant Capacity Assays, Ascorbic Acid Assays, Glutathione Assays, Cell-based Exogenous Antioxidant Assays, Indirect Assays, Lipid-based Assays, Nucleic Acid-based Assays, Protein-based Assays, Enzyme-based Assays, Reactive Oxygen Species-based Assays

Oxidative Stress Assays Market by Technology:

Based on technology, market has been segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy, Chromatography

Oxidative Stress Assays Market by Disease Type:

Based on disease type, market has been segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases, Other Diseases

Cardiovascular Disease segment accounted for largest share due to rising prevalence of cardiovascular diseases and unhealthy lifestyle.

Oxidative Stress Assays Market by End User:

Based on end user, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Cosmetic Companies

Oxidative Stress Assays Market by Region:

North America owns the largest share of this market owing to advanced healthcare infrastructure, rising investments in healthcare, presence of leading players and technological advancement. However, Asia Pacific will grow at the highest CAGR owing to supportive government initiatives, rising awareness, rising investments and rising income.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact of the Oxidative Stress Assays Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Oxidative Stress Assays Market, By Product, 2019-2030 (USD Million)

  • 6.1. Consumables
  • 6.2. Kits
  • 6.3. Reagents
  • 6.4. Instruments
  • 6.5. Services

7. Global Oxidative Stress Assays Market, By Test Type, 2019-2030 (USD Million)

  • 7.1. Antioxidant Capacity Assays
  • 7.2. Ascorbic Acid Assays
  • 7.3. Glutathione Assays
  • 7.4. Cell-based Exogenous Antioxidant Assays
  • 7.5. Indirect Assays
  • 7.6. Lipid-based Assays
  • 7.7. Nucleic Acid-based Assays
  • 7.8. Protein-based Assays
  • 7.9. Enzyme-based Assays
  • 7.10. Reactive Oxygen Species-based Assays

8. Global Oxidative Stress Assays Market, By Technology, 2019-2030 (USD Million)

  • 8.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 8.2. Flow Cytometry
  • 8.3. High-content Screening (HCS)
  • 8.4. Label-free Detection
  • 8.5. Microscopy
  • 8.6. Chromatography

9. Global Oxidative Stress Assays Market, By Disease Type, 2019-2030 (USD Million)

  • 9.1. Cardiovascular Disease
  • 9.2. Diabetes
  • 9.3. Cancer
  • 9.4. Respiratory Diseases
  • 9.5. Other Diseases

10. Global Oxidative Stress Assays Market, By End User, 2019-2030 (USD Million)

  • 10.1. Clinical Laboratories
  • 10.2. Contract Research Organizations
  • 10.3. Pharmaceutical and Biotechnology Companies
  • 10.4. Academic Research Institutes
  • 10.5. Cosmetic Companies

11. Global Oxidative Stress Assays Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Abcam, plc
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. AMS Biotechnology
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Arbor Assays
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. BioVision, Inc.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Callegari SRL
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Cayman Chemical
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Cell Biolabs, Inc.
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Eagle Biosciences, Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Enzo Biochem, Inc.
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Genox Corporation
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Hycult Biotech
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. ImmunoChemistry Technologies, LLC
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Kamiya Biomedical Company
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. MEGA TIP San.Tic.Ltd.Sti.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGaA
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Oxford Biomedical Research
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Promega Corporation
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. QIAGEN N.V.
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. Thermo Fisher Scientific, Inc.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Toxys B.V.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments